Cost-Effective Wastewater Management for Sustainable Urban Development: Evidence from Nagpur City
Frontiers in Health Informatics · 07.12.2024 · 8308-8314
DOI: 10.63682/fhi3083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Health Informatics, online erschienen am 07.12.2024. Verfasst von Anup Manikrao Deshmukh und 1 weiteren Autor:innen.
Abstract (Originalsprache)
In cities of India, the production of wastewater has increased rapidly resulting in environmental and public health concerns. This study focuses on wastewater management solution for the sustainable urban development in Nagpur City in a cost effective manner. A descriptive and analytical research design was employed and primary data were gathered from 400 respondents from whom a stratified random sampling sampling technique was done using a structured questionnaire. The results showed that the public has a positive perception of wastewater reuse and treatment, but high wastewater treatment costs, lack of public awareness and institutional backup are significant barriers. Based on the findings of this study, it is recommended that investment in decentralized treatment technologies, public awareness campaigns and supportive government policies are necessary to improve the effectiveness of wastewater management and sustainability in urban areas..
Zitieren
APA
Deshmukh, A. M., & Patil, P. (2024). Cost-Effective Wastewater Management for Sustainable Urban Development: Evidence from Nagpur City. Frontiers in Health Informatics, 8308-8314. https://doi.org/10.63682/fhi3083
Vancouver
Deshmukh AM, Patil P. Cost-Effective Wastewater Management for Sustainable Urban Development: Evidence from Nagpur City. Frontiers in Health Informatics. 2024:8308-8314. doi:10.63682/fhi3083
BibTeX
@article{Deshmukh2024,
author = {Deshmukh, Anup Manikrao and Patil, Prashant},
title = {Cost-Effective Wastewater Management for Sustainable Urban Development: Evidence from Nagpur City},
journal = {Frontiers in Health Informatics},
year = {2024},
pages = {8308--8314},
doi = {10.63682/fhi3083}
}
EUVIMED